Press

Healthtech Summit is a global conference showcasing the latest technology in the medical and healthcare fields (healthtech) and leading-edge examples of its use. As digitalization of the medical and healthcare fields advances worldwide, the event will provide an opportunity for cutting-edge knowledge and innovation in healthtech from Japan and abroad to be gathered and disseminated, in order to promote the growth of healthtech in Japan.
Gathering the latest trends in the ever-growing healthcare market and participating in further discussions will lead to the creation of new businesses.

Please see below for details of the speakers.

DAY 1 (December 7th) [Venue A] Muromachi Mitsui Hall 15:40-16:40 (1:00)
Title: Tackle Drug Lag and Loss with Tech! Players Seriously Addressing Solutions

Moderator:
Dr. Kenichi Nakamura (Head of International Development, National Cancer Center Hospital/Special Assistant to the Hospital Director)
Panelist:
Hiroshi Yamamoto (Founder and CEO of 88 Therapeutics Inc./Asia Managing Director of Locust Walk Japan LLC)
Panelist/Demonstrator:
Takateru Inokawa (CEO and CEO of Buzzreach Inc.)
Panelist/Demonstrator:
Hiroyuki Kakinoki (Director of DCT Japan Inc./Executive Officer of Integrity Healthcare Inc.)
Panelist/Demonstrator:
Tatsuki Araki (VP, Head of Healthy Living, Fujitsu Limited)

Summary :
Drugs available overseas are not available in Japan. Increasingly serious drug lag and loss is a social issue that robs patients of hope. To overcome this situation, efforts are underway to utilize technology, such as decentralized clinical trials (DCT) and clinical trial platforms. Players who are serious about solving this problem will gather together to discuss the structural problems facing clinical trials in Japan and how to overcome them.

DAY2 (December 8th) [Venue B] Muromachi Mitsui Hall 13:20-14:20 (1:00)
Title: Open Innovation 2.0 in the Health Tech Field – Questioning the Illusion of Open Innovation and True Co-creation –

Moderator:
Shuhei Fujimoto (Associate Professor, Shizuoka Graduate School of Public Health / Open Innovation Partner, Medley Inc.)
Panelists:
Takateru Ikawa (CEO, Buzzreach Inc.)
Panelists:
Hiromi Kawada (CEO, Hedgehog Medtech Inc. (Doctor, MD))

Summary :
Open innovation (OI) is a highly abstract term, and in many cases it has become a mere formality without substance. In this session, we will discuss the diversity of systems that can enable true co-creation between business companies, startups, investors, universities, etc. without becoming a mere formality, as well as the effectiveness of OI, and discuss the state of OI 2.0 in the healthcare field.

For more information about Healthtech Summit 2025, click here